Published in Transpl Infect Dis on July 01, 2007
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach. Antimicrob Agents Chemother (2011) 1.02
How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care (2014) 0.89
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies. Clinicoecon Outcomes Res (2009) 0.82
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain. BMC Pharmacol Toxicol (2014) 0.81
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain. BMC Infect Dis (2012) 0.77
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant (2010) 3.46
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother (2006) 2.65
Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr (1977) 2.36
Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest (2000) 2.18
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. J Clin Oncol (1991) 1.94
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med (2001) 1.84
Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol (1998) 1.84
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect (1998) 1.82
The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*. Int J Clin Pract (2010) 1.64
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Use of allografts after failed treatment of rupture of the anterior cruciate ligament. J Bone Joint Surg Am (1994) 1.54
Management of massive presacral pelvic bleeding in patients with gynecological malignances: review of the literature. Eur J Gynaecol Oncol (2005) 1.54
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med (2005) 1.49
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med (1997) 1.46
Brain protection during circulatory arrest. Ann Thorac Surg (1991) 1.43
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Postoperative drug therapy to extend survival after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.39
Harvey's experiment on occlusion of the vena cava. Ann Thorac Surg (2000) 1.38
Assessing family functioning across three areas of relationships. Nurs Res (1982) 1.34
Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother (2009) 1.31
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol (1993) 1.29
Feasibility of strain and strain rate imaging for the assessment of regional left atrial deformation: a study in normal subjects. Eur J Echocardiogr (2005) 1.29
Coccydynia: a review of pathoanatomy, aetiology, treatment and outcome. J Bone Joint Surg Br (2010) 1.25
Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America. Pharmacoeconomics (1995) 1.24
Percutaneous fixation of the pelvic ring: an update. J Bone Joint Surg Br (2007) 1.22
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J (2001) 1.20
Towards novel paradigms for cancer therapy. Oncogene (2010) 1.18
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clin Infect Dis (1997) 1.17
Candida catenulata fungemia in a cancer patient. J Clin Microbiol (1999) 1.17
Kinetic analysis of the triggered exocytosis/endocytosis secretory cycle in cultured bovine adrenal medullary cells. J Cell Biol (1986) 1.16
A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect (2011) 1.13
Effect of coronary reperfusion on myocardial hemorrhage and infarct healing. Am J Cardiol (1983) 1.11
Patient preferences and assessment of likely adherence to hepatitis C virus treatment. J Viral Hepat (2010) 1.10
Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability. Transpl Infect Dis (1999) 1.09
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma. Ann Oncol (2009) 1.07
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia (2012) 1.07
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Am J Med (1991) 1.05
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis (1995) 1.03
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Br J Cancer (1994) 1.01
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol (1989) 1.01
The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol (2000) 1.00
Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect (2013) 0.99
Cross-sectional area of the proximal portions of the three major epicardial coronary arteries in 98 necropsy patients with different coronary events. Relationship to heart weight, age and sex. Circulation (1980) 0.97
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect (2006) 0.97
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother (2009) 0.96
Health policy issues and applications for evidence-based medicine and clinical practice guidelines. Health Policy (1998) 0.95
Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int (2013) 0.95
Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant (1990) 0.95
Aortic dissection originating in the suprarenal abdominal aorta. J Vasc Surg (1994) 0.94
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect (2012) 0.93
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome. Clin Infect Dis (2000) 0.93
Patterns of Medicaid expenditures after AIDS diagnosis. Health Care Financ Rev (1994) 0.93
Role socialization of graduating student nurses: impact of a nursing practicum on professional role conception. J Prof Nurs (1995) 0.93
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement. Cancer (1992) 0.93
Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients. Bone Marrow Transplant (1989) 0.92
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. J Antimicrob Chemother (2005) 0.92
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus. J Hosp Infect (2005) 0.91
Patient preferences for acute pain treatment. Br J Anaesth (2004) 0.91
Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study. Integr Cancer Ther (2005) 0.90
Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI Study. Eur Heart J (1993) 0.89
Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin Infect Dis (2002) 0.88
Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer. Cancer (1988) 0.87
Late results after triple-valve replacement with various substitute valves. Ann Thorac Surg (1993) 0.87
Nitric oxide decreases renal medullary Na+, K+-ATPase activity through cyclic GMP-protein kinase G dependent mechanism. J Physiol Pharmacol (2003) 0.87
Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. Anticancer Res (2010) 0.87
Wilhelm His, Sr.'s finding of Johann Sebastian Bach. Am J Cardiol (1986) 0.87
European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect (2011) 0.87
Pathologic fracture of the humerus due to metastatic cholangiocarcinoma. South Med J (1999) 0.86
Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer (1998) 0.85
Nutritional assessment and treatment of hospital malnutrition. Infusionsther Klin Ernahr (1979) 0.85
When does the lung die? I. Histochemical evidence of pulmonary viability after "death". J Heart Lung Transplant (1995) 0.85
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect (2012) 0.85
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia (2012) 0.85
High incidence but low burden of coronaviruses and preferential associations between respiratory viruses. J Clin Microbiol (2013) 0.84
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol (1992) 0.84
Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities. Leukemia (2008) 0.84
[Diffuse digestive tract B-cell lymphoma manifesting as exudative enteropathy]. Presse Med (1998) 0.84
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect (2012) 0.84
Coronary arteries in unstable angina pectoris, acute myocardial infarction, and sudden coronary death. Am Heart J (1994) 0.83
Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer (1990) 0.83
Ionic requirements for the active ileal bile salt transport system. J Lipid Res (1976) 0.83
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte. J Clin Oncol (2000) 0.83
Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats. Pol J Pharmacol (2004) 0.83
Early and late remodeling of the left ventricle after acute myocardial infarction. Am J Cardiol (1984) 0.82
An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. Eur J Cancer (2004) 0.81
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis (1999) 0.81
Reproductive response to child mortality: a maximum likelihood estimation model. J Am Stat Assoc (1983) 0.81
Fatal atherosclerotic narrowing of the right main coronary artery: origin of the left anterior descending or left circumflex coronary artery from the right (the true "left-main equivalent"). Am Heart J (1982) 0.81
When does the lung die? II. Ultrastructural evidence of pulmonary viability after "death". J Heart Lung Transplant (1995) 0.81
Mapping the x-ray emission region in a laser-plasma accelerator. Phys Rev Lett (2011) 0.81
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients. Transpl Infect Dis (2013) 0.81
Topographic changes in the left ventricle after experimentally induced myocardial infarction in the rat. Am J Cardiol (1983) 0.81